Impact of the pandemic on rectal cancer diagnosis and treatment
An Analysis of Covid-19 Effect on Patients With Colorectal Cancer - Follow-up Regarding Tumour Stage, Neoadjuvant Treatment, Delay and Long-term Survival
This study looks at how the Covid-19 pandemic has changed the way rectal cancer is diagnosed and treated for patients diagnosed between 2019 and 2022.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT05328960 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates how the Covid-19 pandemic has affected the diagnosis, treatment, and survival outcomes of patients with rectal cancer. It focuses on patients diagnosed between 2019 and 2022, comparing those diagnosed during the pandemic to those diagnosed before. The study aims to understand changes in treatment guidelines and the overall impact on patient care due to the pandemic. By analyzing these factors, the research seeks to provide insights into the long-term effects of delayed diagnoses and altered treatment protocols.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with rectal cancer between 2019 and 2022.
Not a fit: Patients who were not diagnosed with rectal cancer during the specified timeframe will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help improve future diagnosis and treatment strategies for rectal cancer in the context of pandemics.
How similar studies have performed: While the impact of the pandemic on cancer care has been discussed, this specific evaluation of rectal cancer outcomes during this period is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Rectal cancer diagnosis 2019-2022 Exclusion Criteria: * No rectal cancer diagnosis 2019-2022
Where this trial is running
Gothenburg
- Dept. of Surgery, Sahlgrenska University Hospital/Ostra — Gothenburg, Sweden (Recruiting)
Study contacts
- Study coordinator: Eva Angenete, MD. PhD
- Email: eva.angenete@vgregion.se
- Phone: 0760514441
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.